Christian T Farrar1, Jason S Buhrman, Guanshu Liu, Anne Kleijn, Martine L M Lamfers, Michael T McMahon, Assaf A Gilad, Giulia Fulci. 1. From the Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology (C.T.F.), and Brain Tumor Research Center, Department of Neurosurgery (J.S.B., A.K., G.F.), Massachusetts General Hospital and Harvard Medical School, 185 Cambridge St, Simches CRPZN-3800, Boston, MA 02114; F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Md (G.L., M.T.M., A.A.G.), The Russell H. Morgan Department of Radiology and Radiological Science (G.L., M.T.M., A.A.G.), The Johns Hopkins University, Baltimore, Md; Department of Neurosurgery, Josephine Nefkens Institute, Erasmus MC, Rotterdam, the Netherlands (A.K., M.L.M.L.); and Cellular Imaging Section and Vascular Biology Program, Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, Md (A.A.G.).
Abstract
PURPOSE: To (a) evaluate whether the lysine-rich protein (LRP) magnetic resonance (MR) imaging reporter gene can be engineered into G47Δ, a herpes simplex-derived oncolytic virus that is currently being tested in clinical trials, without disrupting its therapeutic effectiveness and (b) establish the ability of chemical exchange saturation transfer (CEST) MR imaging to demonstrate G47Δ-LRP. MATERIALS AND METHODS: The institutional subcommittee for research animal care approved all in vivo procedures. Oncolytic herpes simplex virus G47Δ, which carried the LRP gene, was constructed and tested for its capacity to replicate in cancer cells and express LRP in vitro. The LRP gene was detected through CEST imaging of lysates derived from cells infected with G47Δ-LRP or the control G47Δ-empty virus. G47Δ-LRP was then tested for its therapeutic effectiveness and detection with CEST MR imaging in vivo. Images of rat gliomas were acquired before and 8-10 hours after injection of G47Δ-LRP (n = 7) or G47Δ-empty virus (n = 6). Group comparisons were analyzed with a paired t test. RESULTS: No significant differences were observed in viral replication or therapeutic effectiveness between G47Δ-LRP and G47Δ-empty virus. An increase in CEST image contrast was observed in cell lysates (mean ± standard deviation, 0.52% ± 0.06; P = .01) and in tumors (1.1% ± 0.3, P = .02) after infection with G47Δ-LRP but not G47Δ-empty viruses. No histopathologic differences were observed between tumors infected with G47Δ-LRP and G47Δ-empty virus. CONCLUSION: This study has demonstrated the ability of CEST MR imaging to show G47Δ-LRP at acute stages of viral infection. The introduction of the LRP transgene had no effect on the viral replication or therapeutic effectiveness. This can aid in development of the LRP gene as a reporter for the real-time detection of viral spread. Online supplemental material is available for this article. RSNA, 2015
PURPOSE: To (a) evaluate whether the lysine-rich protein (LRP) magnetic resonance (MR) imaging reporter gene can be engineered into G47Δ, a herpes simplex-derived oncolytic virus that is currently being tested in clinical trials, without disrupting its therapeutic effectiveness and (b) establish the ability of chemical exchange saturation transfer (CEST) MR imaging to demonstrate G47Δ-LRP. MATERIALS AND METHODS: The institutional subcommittee for research animal care approved all in vivo procedures. Oncolytic herpes simplex virus G47Δ, which carried the LRP gene, was constructed and tested for its capacity to replicate in cancer cells and express LRP in vitro. The LRP gene was detected through CEST imaging of lysates derived from cells infected with G47Δ-LRP or the control G47Δ-empty virus. G47Δ-LRP was then tested for its therapeutic effectiveness and detection with CEST MR imaging in vivo. Images of ratgliomas were acquired before and 8-10 hours after injection of G47Δ-LRP (n = 7) or G47Δ-empty virus (n = 6). Group comparisons were analyzed with a paired t test. RESULTS: No significant differences were observed in viral replication or therapeutic effectiveness between G47Δ-LRP and G47Δ-empty virus. An increase in CEST image contrast was observed in cell lysates (mean ± standard deviation, 0.52% ± 0.06; P = .01) and in tumors (1.1% ± 0.3, P = .02) after infection with G47Δ-LRP but not G47Δ-empty viruses. No histopathologic differences were observed between tumors infected with G47Δ-LRP and G47Δ-empty virus. CONCLUSION: This study has demonstrated the ability of CEST MR imaging to show G47Δ-LRP at acute stages of viral infection. The introduction of the LRP transgene had no effect on the viral replication or therapeutic effectiveness. This can aid in development of the LRP gene as a reporter for the real-time detection of viral spread. Online supplemental material is available for this article. RSNA, 2015
Authors: Guanshu Liu; Assaf A Gilad; Jeff W M Bulte; Peter C M van Zijl; Michael T McMahon Journal: Contrast Media Mol Imaging Date: 2010 May-Jun Impact factor: 3.161
Authors: Robin A de Graaf; Peter B Brown; Scott McIntyre; Terence W Nixon; Kevin L Behar; Douglas L Rothman Journal: Magn Reson Med Date: 2006-08 Impact factor: 4.668
Authors: Giulia Fulci; Laura Breymann; Davide Gianni; Kazuhiko Kurozomi; Sarah S Rhee; Jianhua Yu; Balveen Kaur; David N Louis; Ralph Weissleder; Michael A Caligiuri; E Antonio Chiocca Journal: Proc Natl Acad Sci U S A Date: 2006-08-14 Impact factor: 11.205
Authors: Jean C Augustinack; Karl Helmer; Kristen E Huber; Sita Kakunoori; Lilla Zöllei; Bruce Fischl Journal: Front Hum Neurosci Date: 2010-05-28 Impact factor: 3.169
Authors: Nirbhay N Yadav; Craig K Jones; Jiadi Xu; Amnon Bar-Shir; Assaf A Gilad; Michael T McMahon; Peter C M van Zijl Journal: Magn Reson Med Date: 2012-07-26 Impact factor: 4.668
Authors: Wojciech G Lesniak; Nikita Oskolkov; Xiaolei Song; Bachchu Lal; Xing Yang; Martin Pomper; John Laterra; Sridhar Nimmagadda; Michael T McMahon Journal: Nano Lett Date: 2016-03-01 Impact factor: 11.189
Authors: Or Perlman; Kai Herz; Moritz Zaiss; Ouri Cohen; Matthew S Rosen; Christian T Farrar Journal: Magn Reson Med Date: 2019-08-09 Impact factor: 4.668
Authors: Ouri Cohen; Shuning Huang; Michael T McMahon; Matthew S Rosen; Christian T Farrar Journal: Magn Reson Med Date: 2018-05-13 Impact factor: 4.668
Authors: Il Minn; Amnon Bar-Shir; Keerthi Yarlagadda; Jeff W M Bulte; Paul B Fisher; Hao Wang; Assaf A Gilad; Martin G Pomper Journal: Magn Reson Med Date: 2015-04-27 Impact factor: 4.668